Strides Pharma Science is a finished-dose manufacturer based in India. It appears in 88 regulatory filings across 12 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA, EFDA (ET) and NCELS (KZ). Its GMP standing is certified by EMA, CDSCO (India) and MHRA (UK), among 6 authorities. Its most recent recorded inspection, by US FDA, closed on 5 April 2024 as VAI. Customs aggregates show $247.1M of exports covering 3,798 molecules to 63 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Bangalore, United Arab Emirates | Not on file |
| BANGALORE, India | Not on file |
| PUDUCHERRY, India | Not on file |
| Bengaluru, India | 3004554612 |
| bengaluru 560 099, India | Not on file |
| Periyakalapet, India | 3012448465 |
3 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 48 | 1 |
| EFDA (ET) | 6 | None |
| NCELS (KZ) | 6 | None |
| TMDA (TZ) | 5 | None |
| UZPHARM (UZ) | 5 | None |
| ZAMRA (ZM) | 4 | None |
| EMA | None | 5 |
| CDSCO (India) | None | 4 |
| MHRA (UK) | None | 2 |
| NAFDAC (NG) | None | 2 |
| ANVISA (Brazil) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $247.1M | 63 |
| 2024 | Not reported | $253.8M | 69 |
| 2023 | Not reported | $245.2M | 74 |
| 2022 | Not reported | $224.0M | 86 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Strides Pharma Science comes back tiered against every other supplier able to file there.
Start for free